Cargando…

The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study

BACKGROUND: Several GI peptides linked to intestinal barrier function could be involved in the modification of intestinal permeability and the onset of diarrhea during adjuvant chemotherapy. The aim of the study was to evaluate the circulating levels of zonulin, glucagon-like peptide-2 (GLP-2), epid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russo, Francesco, Linsalata, Michele, Clemente, Caterina, D’Attoma, Benedetta, Orlando, Antonella, Campanella, Giovanna, Giotta, Francesco, Riezzo, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575294/ https://www.ncbi.nlm.nih.gov/pubmed/23379680 http://dx.doi.org/10.1186/1471-2407-13-56

Ejemplares similares

Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control study
por: Linsalata, Michele, et al.
Publicado: (2018)

Adipose Tissue-Derived Biomarkers of Intestinal Barrier Functions for the Characterization of Diarrhoea-Predominant IBS
por: Russo, Francesco, et al.
Publicado: (2018)

Noninvasive Biomarkers of Gut Barrier Function in Patients Suffering from Diarrhea Predominant-IBS: An Update
por: Linsalata, Michele, et al.
Publicado: (2020)

Psychological and Gastrointestinal Symptoms of Patients with Irritable Bowel Syndrome Undergoing a Low-FODMAP Diet: The Role of the Intestinal Barrier
por: Prospero, Laura, et al.
Publicado: (2021)

The Relationship between Low Serum Vitamin D Levels and Altered Intestinal Barrier Function in Patients with IBS Diarrhoea Undergoing a Long-Term Low-FODMAP Diet: Novel Observations from a Clinical Trial
por: Linsalata, Michele, et al.
Publicado: (2021)

Somatization in patients with predominant diarrhoea irritable bowel syndrome: the role of the intestinal barrier function and integrity
por: Prospero, Laura, et al.
Publicado: (2021)

Colonic Transit Time and Gut Peptides in Adult Patients with Slow and Normal Colonic Transit Constipation
por: Riezzo, Giuseppe, et al.
Publicado: (2017)

Managing Symptom Profile of IBS-D Patients With Tritordeum-Based Foods: Results From a Pilot Study
por: Russo, Francesco, et al.
Publicado: (2022)

A Comparison of the Low-FODMAPs Diet and a Tritordeum-Based Diet on the Gastrointestinal Symptom Profile of Patients Suffering from Irritable Bowel Syndrome-Diarrhea Variant (IBS-D): A Randomized Controlled Trial
por: Russo, Francesco, et al.
Publicado: (2022)

Corrigendum: Managing symptom profile of IBS-D patients with Tritordeum-based foods: results from a pilot study
por: Russo, Francesco, et al.
Publicado: (2023)

A Tritordeum-Based Diet for Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome: Effects on Abdominal Bloating and Psychological Symptoms
por: Riezzo, Giuseppe, et al.
Publicado: (2023)

Improved Symptom Profiles and Minimal Inflammation in IBS-D Patients Undergoing a Long-Term Low-FODMAP Diet: A Lipidomic Perspective
por: Orlando, Antonella, et al.
Publicado: (2020)

The Role of Intestinal Barrier Function in Overweight Patients with IBS with Diarrhea Undergoing a Long-Term Low Fermentable Oligo-, Di-, and Monosaccharide and Polyol Diet
por: Linsalata, Michele, et al.
Publicado: (2023)

Vitamin K1 Exerts Antiproliferative Effects and Induces Apoptosis in Three Differently Graded Human Colon Cancer Cell Lines
por: Orlando, Antonella, et al.
Publicado: (2015)

Lactobacillus rhamnosus GG Protects the Epithelial Barrier of Wistar Rats from the Pepsin-Trypsin-Digested Gliadin (PTG)-Induced Enteropathy
por: Orlando, Antonella, et al.
Publicado: (2018)

A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer
por: Ishiguro, Hiroshi, et al.
Publicado: (2020)

The Effects of a Very-Low-Calorie Ketogenic Diet on the Intestinal Barrier Integrity and Function in Patients with Obesity: A Pilot Study
por: Linsalata, Michele, et al.
Publicado: (2023)

The Impact of a Twelve-Week Moderate Aerobic Exercise Program on Gastrointestinal Symptom Profile and Psychological Well-Being of Irritable Bowel Syndrome Patients: Preliminary Data from a Southern Italy Cohort
por: Riezzo, Giuseppe, et al.
Publicado: (2023)

A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01)
por: Riccardi, A, et al.
Publicado: (2001)

Enhanced Physical Capacity and Gastrointestinal Symptom Improvement in Southern Italian IBS Patients following Three Months of Moderate Aerobic Exercise
por: Bianco, Antonella, et al.
Publicado: (2023)

Lactobacillus Rhamnosus GG Affects the BDNF System in Brain Samples of Wistar Rats with Pepsin-Trypsin-Digested Gliadin (PTG)-Induced Enteropathy
por: Orlando, Antonella, et al.
Publicado: (2020)

Evaluation of the Effects of the Tritordeum-Based Diet Compared to the Low-FODMAPs Diet on the Fecal Metabolome of IBS-D Patients: A Preliminary Investigation
por: Caponio, Giusy Rita, et al.
Publicado: (2022)

Phase II multicentre randomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer
por: Bonneterre, J, et al.
Publicado: (2004)

The Ketogenic Diet Reduces the Harmful Effects of Stress on Gut Mitochondrial Biogenesis in a Rat Model of Irritable Bowel Syndrome
por: Chimienti, Guglielmina, et al.
Publicado: (2021)

The Mitochondrial Trigger in an Animal Model of Nonalcoholic Fatty Liver Disease
por: Chimienti, Guglielmina, et al.
Publicado: (2021)

Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer
por: Zhang, Minmin, et al.
Publicado: (2016)

Fibres and Colorectal Cancer: Clinical and Molecular Evidence
por: Celiberto, Francesca, et al.
Publicado: (2023)

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy
por: Ohno, S., et al.
Publicado: (2013)

Effects of a Very-Low-Calorie Ketogenic Diet on the Fecal and Urinary Volatilome in an Obese Patient Cohort: A Preliminary Investigation
por: Celano, Giuseppe, et al.
Publicado: (2023)

Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients.
por: van der Wall, E., et al.
Publicado: (1996)

Nab-Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide in Neoadjuvant Chemotherapy for Resectable Breast Cancer: A Phase II Trial
por: Kin, Takanori, et al.
Publicado: (2020)

Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM).
por: Colucci, G., et al.
Publicado: (1995)

Lactobacillus GG restoration of the gliadin induced epithelial barrier disruption: the role of cellular polyamines
por: Orlando, Antonella, et al.
Publicado: (2014)

FEC91 migration FEC vers DSC
por: Serre, C
Publicado: (1990)

FEC91 Migration FEC vers DSC
por: Serre, C
Publicado: (1990)

FEC91 Migration FEC vers DSC
por: Serre, C
Publicado: (1990)

FEC91 Migration FEC vers DSC
por: Serre, C
Publicado: (1990)

FEC91 Migration FEC vers DSC
por: Serre, C
Publicado: (1990)

FEC91 Migration FEC vers DSC
por: Serre, C
Publicado: (1990)

Fluorouracil Catabolism in the Combination Treatment of Cyclophosphamide, Methotrexate and Fluorouracil
por: De Bruijn, Ernst A., et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_fbbvqeqsomv0ldegjm2ueqlmlr